- Presentations
- 2
- Markets
- 1
Lunsumio Velo is a brand of Mosunetuzumab marketed by Genentech, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Mosunetuzumab
- Brand owner
- Genentech
- Registered in
- United States
- Strengths and forms
- 45 mg/1 mL injection, 5 mg/0.5 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Lunsumio Velo 45 mg/1 mL injectionSubcutaneous Cold chain | Genentech | US FDA | Available on request |
| Lunsumio Velo 5 mg/0.5 mL injectionSubcutaneous Cold chain | Genentech | US FDA | Available on request |
Equivalent brands
Other brands of Mosunetuzumab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Lunsumio Velo
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.